Cargando…

Encapsulation of Clofazimine by Cyclodextran: Preparation, Characterization, and In Vitro Release Properties

This study aimed to evaluate and compare the efficacy of cyclodextrans (CIs) and cyclodextrins (CDs) in improving the water solubility of a poorly water-soluble drug, clofazimine (CFZ). Among the evaluated CIs and CDs, CI-9 exhibited the highest percentage of drug inclusion and the highest solubilit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Seong-Jin, Kim, Young-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218955/
https://www.ncbi.nlm.nih.gov/pubmed/37240153
http://dx.doi.org/10.3390/ijms24108808
_version_ 1785048896241664000
author Hong, Seong-Jin
Kim, Young-Min
author_facet Hong, Seong-Jin
Kim, Young-Min
author_sort Hong, Seong-Jin
collection PubMed
description This study aimed to evaluate and compare the efficacy of cyclodextrans (CIs) and cyclodextrins (CDs) in improving the water solubility of a poorly water-soluble drug, clofazimine (CFZ). Among the evaluated CIs and CDs, CI-9 exhibited the highest percentage of drug inclusion and the highest solubility. Additionally, CI-9 showed the highest encapsulation efficiency, with a CFZ:CI-9 molar ratio of 0.2:1. SEM analysis indicated successful formation of inclusion complexes CFZ/CI and CFZ/CD, accounting for the rapid dissolution rate of the inclusion complex. Moreover, CFZ in CFZ/CI-9 demonstrated the highest drug release ratio, reaching up to 97%. CFZ/CI complexes were found to be an effective means of protecting the activity of CFZ against various environmental stresses, particularly UV irradiation, compared to free CFZ and CFZ/CD complexes. Overall, the findings provide valuable insights into designing novel drug delivery systems based on the inclusion complexes of CIs and CDs. However, further studies are needed to investigate the effects of these factors on the release properties and pharmacokinetics of encapsulated drugs in vivo, in order to ensure the safety and efficacy of these inclusion complexes. In conclusion, CI-9 is a promising candidate for drug delivery systems, and CFZ/CI complexes could be a potential formulation strategy for the development of stable and effective drug products.
format Online
Article
Text
id pubmed-10218955
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102189552023-05-27 Encapsulation of Clofazimine by Cyclodextran: Preparation, Characterization, and In Vitro Release Properties Hong, Seong-Jin Kim, Young-Min Int J Mol Sci Article This study aimed to evaluate and compare the efficacy of cyclodextrans (CIs) and cyclodextrins (CDs) in improving the water solubility of a poorly water-soluble drug, clofazimine (CFZ). Among the evaluated CIs and CDs, CI-9 exhibited the highest percentage of drug inclusion and the highest solubility. Additionally, CI-9 showed the highest encapsulation efficiency, with a CFZ:CI-9 molar ratio of 0.2:1. SEM analysis indicated successful formation of inclusion complexes CFZ/CI and CFZ/CD, accounting for the rapid dissolution rate of the inclusion complex. Moreover, CFZ in CFZ/CI-9 demonstrated the highest drug release ratio, reaching up to 97%. CFZ/CI complexes were found to be an effective means of protecting the activity of CFZ against various environmental stresses, particularly UV irradiation, compared to free CFZ and CFZ/CD complexes. Overall, the findings provide valuable insights into designing novel drug delivery systems based on the inclusion complexes of CIs and CDs. However, further studies are needed to investigate the effects of these factors on the release properties and pharmacokinetics of encapsulated drugs in vivo, in order to ensure the safety and efficacy of these inclusion complexes. In conclusion, CI-9 is a promising candidate for drug delivery systems, and CFZ/CI complexes could be a potential formulation strategy for the development of stable and effective drug products. MDPI 2023-05-15 /pmc/articles/PMC10218955/ /pubmed/37240153 http://dx.doi.org/10.3390/ijms24108808 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hong, Seong-Jin
Kim, Young-Min
Encapsulation of Clofazimine by Cyclodextran: Preparation, Characterization, and In Vitro Release Properties
title Encapsulation of Clofazimine by Cyclodextran: Preparation, Characterization, and In Vitro Release Properties
title_full Encapsulation of Clofazimine by Cyclodextran: Preparation, Characterization, and In Vitro Release Properties
title_fullStr Encapsulation of Clofazimine by Cyclodextran: Preparation, Characterization, and In Vitro Release Properties
title_full_unstemmed Encapsulation of Clofazimine by Cyclodextran: Preparation, Characterization, and In Vitro Release Properties
title_short Encapsulation of Clofazimine by Cyclodextran: Preparation, Characterization, and In Vitro Release Properties
title_sort encapsulation of clofazimine by cyclodextran: preparation, characterization, and in vitro release properties
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218955/
https://www.ncbi.nlm.nih.gov/pubmed/37240153
http://dx.doi.org/10.3390/ijms24108808
work_keys_str_mv AT hongseongjin encapsulationofclofaziminebycyclodextranpreparationcharacterizationandinvitroreleaseproperties
AT kimyoungmin encapsulationofclofaziminebycyclodextranpreparationcharacterizationandinvitroreleaseproperties